Predictive Performance of Serum S100B Versus LDH in Melanoma Patients: A Systematic Review and Meta-Analysis

BACKGROUND: Currently, no consensus on the use of blood tests for monitoring disease recurrence in patients with resected melanoma exists. The only meta-analysis conducted in 2008 found that elevated serum S100B levels were associated with significantly worse survival in melanoma patients. Serum LDH...

Descripción completa

Detalles Bibliográficos
Autores principales: Janka, Eszter Anna, Várvölgyi, Tünde, Sipos, Zoltán, Soós, Alexandra, Hegyi, Péter, Kiss, Szabolcs, Dembrovszky, Fanni, Csupor, Dezső, Kéringer, Patrik, Pécsi, Dániel, Solymár, Margit, Emri, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688362/
https://www.ncbi.nlm.nih.gov/pubmed/34950582
http://dx.doi.org/10.3389/fonc.2021.772165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688362/
https://www.ncbi.nlm.nih.gov/pubmed/34950582
http://dx.doi.org/10.3389/fonc.2021.772165

Ejemplares similares